- $180.81m
- $20.73m
- $53.43m
Brief: Invivyd Prices Public Offering At $0.52 Per Share
Brief: Invivyd Announces Proposed Public Offering Of Common Stock
Brief: Invivyd Announces Continued Neutralizing Activity Of Pemgarda And VYD2311 Against Currently Dominant Sars-Cov-2 Variant XFG
Brief: Invivyd Q2 EPS USD -0.12
Invivyd Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Invivyd Announces Positive Full Phase 1/2 Clinical Data For Vyd2311
Invivyd Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Invivyd Q1 EPS USD -0.14
Invivyd Inc expected to post a loss of 3 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Hims & Hers Health, TXNM Energy, Forge Global
U.S. STOCKS ON THE MOVE-Fox, Manpower Group, US chipmakers
U.S. STOCKS ON THE MOVE-NRG Energy, US drugmakers, KindlyMD
Invivyd rises on plan to test measles antibody treatment
Brief: Invivyd Announces New Pipeline Discovery Program
Invivyd Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Invivyd Announces $30M Non-Dilutive Loan Facility With Silicon Valley Bank
U.S. STOCKS ON THE MOVE-Starbucks, Bristol Myers Squibb, Home Depot
U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities
U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop